Ultrasound Guided Axillary Nerve Block Compared to Hematoma Block in Patients With Closed Reposition of Distal Forearm Fractures
Ultrasound-guided Axillary Nerve Block Trial
1 other identifier
interventional
117
1 country
1
Brief Summary
Rationale: For distal forearm fractures the investigators propose an anaesthetic method using an ultrasound guided axillary nerve block (ANB, an established technique) for pain reduction during reposition dislocated fractures. Nowadays a fracture hematoma block (FHB) is common practice, but is suboptimal due to variability between performing physicians and is often experienced as a painful procedure. The investigators want to investigate if ANB is an effective, safe and efficient option in pain reduction in patients of an ED (emergency department) population with a distal forearm fracture. Objective: To compare ultrasound-guided ANB with FHB for analgesia during reposition of non-operatively treated forearm fractures Study design: A randomized controlled trial. Study population: Patients ≥ 16 years of age with a closed, isolated and displaced distal forearm fracture requiring manipulative reposition. Intervention (if applicable): The intervention group will receive an ANB on the ipsilateral arm of the fracture. The control group will get a FHB. Main study parameters/endpoints: The primary outcome is pain score on a 11-point NRS (numeric rating scale) (0-10) during closed reposition of the dislocated distal forearm fracture in both groups. Main endpoint of this study is achieving a reduction of at least 2 points between both groups. This is considered as clinical relevant. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients participating in the research group are believed to have less pain and more comfort during reposition of the dislocated fracture. The investigators expect no other or more complications compared to standard care since the known complications are the same for both infiltrative anaesthetic interventions and are rare. Moreover, both procedures are common practice, therefore potential complications will be taken care of properly. The investigators expect there is no prolonged length of stay in the ED.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
December 21, 2022
CompletedFirst Posted
Study publicly available on registry
January 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 28, 2023
CompletedNovember 29, 2023
November 1, 2023
2.4 years
December 21, 2022
November 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Pain score
The primary outcome is pain measured on a pain score using a 11-point NRS (0-10) during closed reposition of the dislocated distal forearm fracture in both groups
15 minutes
Study Arms (2)
Intervention group
EXPERIMENTALThe intervention group will receive an axillary plexus nerve block as pain reduction before the fracture repositioning.
Control group
ACTIVE COMPARATORThe control group will receive a fracture hematoma block as pain reduction before the fracture repositioning.
Interventions
Axillary plexus nerve block: an ultrasound-guided axillary plexus nerve block with a single injection of lidocaine 1%.
Fracture hematoma block: a blinded single injection into the fracture with lidocaine 1%.
Eligibility Criteria
You may qualify if:
- Patients in the ED with a X-ray confirmed dislocated distal forearm fracture, defined as fracture \< 3cm within the radiocarpal joint with an abnormal anatomic position (dorsal angulation \>10°, volar angulation \>20°, radioulnar inclination \<15°, \>5mm radial collapse or intra-articular incongruence \>2mm.
- ≥ 16 years of age
- Patients who have adequate knowledge and understanding of the Dutch language
You may not qualify if:
- 'Open' fractures requiring surgery
- Multi-trauma patients
- Abnormal neurovascular examination requiring immediate reposition or surgery
- Pre-existent osteosynthesis material in situ on the present fracture site.
- Skin injury, local infection or recent burns hindering the use of ultrasound.
- Allergy for local anaesthetics
- Inability to give informed consent (cognitive impairments, no good understanding of the Dutch or English language)
- Severe coagulopathy (i.e. severe thrombocytopenia, haemophilia.). Usage of anticoagulation is not an contra-indication, since any bleeding complication has few adverse consequences(20).
- High risk on compartment syndrome (in consultation with surgery department).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medisch centrum Leeuwarden
Leeuwarden, Provincie Friesland, 8934AD, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Heleen Lameijer, Dr
Heleen.Lameijer1@mcl.nl
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
December 21, 2022
First Posted
January 6, 2023
Study Start
July 1, 2021
Primary Completion
November 28, 2023
Study Completion
November 28, 2023
Last Updated
November 29, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share